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Summary
Hydrolethalus syndrome is a recessively inherited lethal
malformation syndrome characterized by hydrocephaly
with absent midline structures of the brain, micro-
gnathia, polydactyly, and several other abnormalities,
mostly in the midline structures. Hydrolethalus syn-
drome was described in 1981 in Finland, where the in-
cidence is 1:20,000. Only a few cases have been reported
elsewhere, and the pathogenesis has remained unknown.
Here we report the assignment of the hydrolethalus syn-
drome locus to chromosome 11q23-25 in Finnish fam-
ilies. The initial genome scan was performed using DNA
samples from only 15 affected individuals. In the next
step, the hydrolethalus syndrome locus was assigned to
an 8.5-cM interval between markers D11S4144 and
D11S1351 by linkage analysis in eight families. Finally,
the critical locus could be restricted by linkage disequi-
librium and haplotype analyses to a 0.5–1-cM region
between markers D11S933 and D11S934. Genealogical
studies performed in 40 families affected by hydrole-
thalus revealed no regional clustering, suggesting a rel-
atively early introduction of the disease mutation into
the Finnish population and the spreading of the muta-
tion with the inhabitation of the late-settlement area.
Introduction
Hydrolethalus syndrome (MIM 236680) is a multiple
midline malformation syndrome leading to stillbirth or
death during the first day of life. The hallmark features
include external hydrocephaly with absent midline struc-
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tures of the brain, polyhydramnions, and micrognathia.
Most patients also have polydactyly, anomalous eyes
and nose, and a keyhole-shaped defect of the occipital
bone. A cleft lip or palate, anomalous or low-set ears,
abnormal larynx or trachea, defective lobulation of the
lungs, congenital heart defect, abnormal genitalia, and
club feet are often present (fig. 1). The syndrome shows
an autosomal recessive mode of inheritance (Salonen et
al. 1981; Salonen and Herva 1990).
Hydrolethalus syndromewas first described in Finland
(Salonen et al. 1981), where it occurs much more fre-
quently than elsewhere in the world. Several hydrole-
thalus cases have been reported in other populations,
but they may not all represent the same phenotypic en-
tity. However, some reports reveal a clinical phenotype
similar to Finnish cases and could represent true hydro-
lethalus cases (Muenke et al. 1991; Sharma et al. 1992;
Pryde et al. 1993; Norgard et al. 1996). Since 1970, 57
families with 81 children affected with hydrolethalus
syndrome have been identified in Finland, and the in-
cidence in this population has been approximated to be
at least 1:20,000 (Salonen and Herva 1990). Hydro
lethalus syndrome thus belongs to the Finnish disease
heritage (Norio et al. 1973), which consists of about 35
monogenic diseases, which have been intensively stud-
ied. Almost all Finnish disease loci have been mapped
to well-defined chromosomal regions, and, in about half
of the diseases, the causative genes have been identified
(Peltonen 1997).
Here we report the assignment of the hydrolethalus
syndrome locus to 11q23-25 by use of linkage, linkage-
disequilibrium, and haplotype analyses in Finnish fam-
ilies. We also performed extensive genealogical studies
that complement the genealogical data published earlier
(Salonen et al. 1981).
Subjects and Methods
Family Material, Controls, DNA Samples, and
Genealogy
Fifteen affected individuals and 20 healthy family
members from eight families affected by hydrolethalus
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Figure 1 Male fetus with hydrolethalus syndrome (case 1a) after termination of pregnancy at 18 wk. Note hydrocephaly, small and wide-
spaced eyes, anomalous bifid nose, bilateral cleft lip, micrognathia, low-set ears, broad neck, polydactyly in both hands and feet, and shortened
lower limbs with club-foot deformity.
were included in the linkage studies. In addition, seven
affected individuals from different families and the par-
ents of four of these families were included in the link-
age-disequilibrium studies. The pedigrees are shown in
figure 2. No relationships could be established between
these families, but the parents of family 8 were first
cousins.
Two of the 22 affected individuals were born, in 1981
and 1991, and the remaining 20 were fetuses aborted
between 1982 and 1998 as a result of ultrasonography
diagnosis (gestational age 10–23 weeks). All the families
included represented very typical cases, and all the di-
agnoses were confirmed by one clinician (R.S.). All the
cases exhibited hydrocephaly and several other malfor-
mations typical of hydrolethalus syndrome. The phe-
notypic features of the affected individuals included in
the linkage and linkage-disequilibrium studies are pre-
sented in table 1.
Forty-one parental DNA samples collected for the
mapping of infantile-onset spinocerebellar ataxia
(IOSCA) and a new lethal metabolic syndrome with iron
accumulation were used as controls for the linkage-dis-
equilibrium analyses. These diseases also belong to the
Finnish disease heritage and are regionally distributed
in a similar way to hydrolethalus syndrome (Varilo et
al. 1996; Fellman et al. 1998). We have recently used
this principle successfully to select controls for the map-
ping of the new Finnish metabolic syndrome with iron
accumulation (Visapa¨a¨ et al. 1998).
DNA from the affected individuals was extracted from
fresh tissue samples obtained at autopsy (placenta, liver)
or from cultured fibroblasts, in accordance with stan-
dard procedures (Maniatis et al. 1982), except for the
affected individuals of family 2, for whom only paraffin-
embedded tissue samples were available. DNA from the
paraffin-embedded tissues was extracted as described
elsewhere (Isola et al. 1994). DNA from the healthy
family members and controls was extracted from pe-
ripheral blood leukocytes, in accordance with standard
procedures.
The genealogical study was performed in accordance
with published criteria (Varilo et al. 1996). The names,
dates, and places of birth of the patients’ parents were
used to trace ancestors of the 40 families affected by
hydrolethalus back to the 1800s, from local church reg-
isters. Eighteen of the core families have been described
before (Salonen et al. 1981). This study was approved
by the Ethical Committee of the Department of Ob-
stetrics and Gynecology at Helsinki University Central
Hospital.
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Figure 2 Pedigrees used in the linkage and linkage-disequilib-
rium studies. Asterisks and triangles indicate individuals from whom
DNA samples were available. Individuals marked with asterisks were
used in linkage and linkage-disequilibrium analyses, and those marked
with triangles provided information for linkage-disequilibrium studies
only. Individuals affected with hydrolethalus syndrome are marked
with blackened symbols. In most cases, the pregnancy was terminated,
after prenatal diagnosis by ultrasound. Only the first affected children
in families 3, 8, 13, and 14 were delivered. S tillborn (hydrole-B = s
thalus-syndrome status not known), ermination of a pregnancy18tr = t
with trisomy 18 but not hydrolethalus syndrome.
Marker Genotyping, Radiation-Hybrid Mapping, and
Statistics
A slightly modified Weber screening set (Sheffield et
al. 1995) of 380 polymorphic microsatellite markerswas
used in the initial genome screen. In the denser mapping
of the critical region on chromosome 11, the Ge´ne´thon
marker set (Dib et al. 1996) was used. To define the
marker order and distances, radiation-hybrid (RH)map-
ping of the markers in the critical region was performed
with the Stanford medium resolution (G3) radiation-
hybrid panel (Research Genetics). Markers D11S4094,
D11S4464, D11S1752, D11S933, D11S4158, and
D11S1896 were typed twice in the G3 panel.Withmark-
ers D11S1353, D11S1328, D11S934, D11S4110,
D11S1351, and D11S912, raw hybrid data for the same
panel were obtained from the Stanford Human Genome
Center Internet pages. The Genome Database was used
to identify the chromosomal band where the critical
markers were located.
The markers were amplified for genotyping by PCR
with fluorescently labeled primers, and the PCR prod-
ucts were electrophoretically separated with an ABI 377
sequencer (PE Biosystems). The genotype data were
processed with the Genotyper computer program, ver-
sion 2.0 (PE Biosystems). For the typing of the RH panel,
the markers were amplified by PCR, and the products
were separated by electrophoresis on 1.5% agarose gels
stained with ethidium bromide.
Two-point linkage analyses were performed using the
MLINK option of the LINKAGE package computer pro-
grams, version FASTLINK 2.2 (Lathrop and Lalouel
1984), assuming autosomal recessive inheritance, com-
plete penetrance, and no phenocopies. The allele fre-
quencies of the polymorphic markers were determined
on the basis of the control samples used for the linkage-
disequilibrium analyses. The consanguinity of the par-
ents of family 8 was taken into account in the linkage
analysis. Two-point and multipoint linkage-disequilib-
rium analyses were performed using the DISLAMB and
DISMULT computer programs, respectively (Terwilliger
1995). A disease-allele frequency of .01 was assumed in
the analyses.
The RH mapping data were analyzed with version
3.0 of the FORTRAN program RHMAXLIK of the
RHMAP package (Boehnke et al. 1991), using the
branch and bound ordering option. This program orders
markers and calculates marker distances in centirays
(cR). The marker distances were converted from centi-
rays to centimorgans (cM) by dividing the known total
distance (in centimorgans, in accordance with Dib et al.
1996) of the region proportional to the marker distances
in centirays.
Results
Genealogical studies of all the available 40 families
affected by hydrolethalus, going back 3–10 generations,
revealed a similar general distribution of ancestors, as
reported elsewhere with a smaller number of families
(Salonen et al. 1981). The birthplaces of the great-grand-
parents were distributed over a relatively wide geograph-
ical area in late-settlement eastern and central Finland,
outside the densely populated early-settlement area of
southern and western Finland (fig. 3). Six parents were
found to be related. The earliest identified link between
ancestors was seven generations (i.e., 220 years) old (fig.
4), and the most recent link was found in family 8, where
the parents were first cousins.
The initial genome scan was performed using theDNA
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Table 1
Findings for the 22 Affected Individuals Included in the Linkage and Linkage-Disequilibrium Studies
MALFORMATION
FAMILY
1a 1b 2a 2b 3a 3b 4a 4ba 5a 5b 6a 6b 7a 7b 8c 9 10 11 12 13b 14 15
Hydrocephalus                      
Occipital bone defect ?  ? ?           ?       
Micrognathia        ?             ? 
Cleft lip/palate        ?              
Anomalous nose    ?    ?             ? ?
Small/deep-set eyes   ? ?    ?       ?       ?
Anomalous/low-set
ears
   ?    ?              
Abnormal larynx/
trachea
       ?              
Defective lobation
of the lungs
       ?              
Congenital heart
defect
       ?            ?  
Urinary-tract
anomalies
       ?              
Abnormal genitalia        ?  ?            
Uterus duplexb m m m  m m m m m m   m  m m    m  m
Polydactyly:                      
Of fingers                      
Of toes                      
Duplicated big toe    ?    ?              
Club feet        ?          ?   ? 
Short limbs   ?     ?             ? 
NOTE.— = Malformation present;  = malformation absent; ? = status not known.
a After suction curettage, at 105 wk of gestation, a thorough examination of the fetus was not possible.
b ale individual.m = M
of 15 individuals—seven affected sibpairs and one af-
fected individual in family 8. Since the parents in family
8 were first cousins, we assumed that the affected in-
dividual would be homozygous with the markers flank-
ing the disease locus. In the first stage of the genome
scan, the genotypes were analyzed simply by comparing
the genotypes of each sibpair, searching for shared al-
leles, and monitoring for homozygosity of the affected
individual in family 8. Several markers revealed shared
genotypes between six of the seven sibpairs, but those
regions were not analyzed further because the adjacent
markers (on average, 10 cM apart) did not show any
tendency to allele sharing. After we had analyzed 270
markers, one marker, D11S4464, revealed identical gen-
otypes in all seven sibpairs. With marker D11S1998, 8
cM centromeric from D11S4464, four sibpairs also
shared identical genotypes, and with the next telomeric
marker, D11S912, 11 cM from D11S4464, five sibpairs
carried identical genotypes. All three markers also re-
vealed homozygosity of the affected individual in family
8. These three markers were then genotyped in the com-
plete family material. No obligatory recombinations
were identified between hydrolethalus syndrome and
marker D11S4464, which provided a LOD score of 3.77
at recombination fraction (v) 0. The maximum LOD
score with marker D11S912 was 2.04 at ,v = .05
whereas marker D11S1998 was uninformative.
In the next phase, we analyzed several markers around
marker D11S4464 in the complete family material and
constructed haplotypes spanning the region. Several
markers within an 8.5-cM region on chromosome
11q23-25, flanked by markers D11S4144 and
D11S1351, provided some evidence of linkage. There
were positive LOD scores (2.7–4.7) with nine markers
over this interval at (table 2). The disease chro-v = 0
mosomes of the parents of family 8 revealed identical
haplotypes over the complete region.
To restrict the critical chromosomal region, we mon-
itored for linkage disequilibrium in the alleles of the nine
markers revealing linkage (table 3). Thirty hydrolethalus
chromosomes and 105 control chromosomes, including
23 chromosomes of the healthy parents in families af-
fected by hydrolethalus and 41 DNA samples from re-
gionally selected controls, were used in these analyses.
In two-point linkage-disequilibrium analyses, twomark-
ers provided highly significant P values. With marker
D11S1896, all the hydrolethalus chromosomes carried
the same allele 4, which was present in 33% of the
control chromosomes, and, with marker D11S4158,
77% of the disease chromosomes carried allele 1, which
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Figure 4 Pedigree of the oldest traced family connection of the
Finnish families affected by hydrolethalus. Their common ancestors
originated from the parish of Ruokolahti, in eastern Finland, and were
born in 1761 and 1764.
Figure 3 Birthplaces of the great-grandparents of 40 families
affected by hydrolethalus on the map of Finland. The birthplaces are
mostly distributed in the late-settlement area, outside the densely pop-
ulated southern and western parts of Finland.
was present in only 16% of the control chromosomes.
The corresponding P values were 4#1013 for marker
D11S1896 and 2#109 for marker D11S4158.
To confirm the marker order, for multipoint linkage-
disequilibrium analysis and for reliable construction of
haplotypes of disease chromosomes, we performed RH
mapping of the linked markers to define their order. The
most probable marker order and the approximate
marker distances (converted to centimorgans) over the
critical region were: cen-D11S4094-0.6 cM-D11S4464-
1.3 cM-D11S1328-0.3 cM-D11S1752-0.1 cM-
D11S933-0.8 cM-D11S4158-0.3 cM-D11S1896-0.1
cM-D11S934-1.9 cM-D11S4110-tel.
Multipoint linkage-disequilibrium analysis was per-
formed with the critical markers (fig. 5). The maximum
LOD score of 21.1 was obtained at the position of
marker D11S4158. A LOD score 120 was obtained be-
tween markers D11S933 and D11S934. To identify the
most probable location of the disease gene, we moni-
tored for a shared ancestral haplotype between the dis-
ease chromosomes (table 4). Based on haplotype sharing,
it was concluded that the hydrolethalus locus lay in the
vicinity of markers D11S4158 and D11S1896. Every
disease chromosome carried the same allele 4 with
marker D11S1896, and 23 of 30 disease chromosomes
carried the same allele 1 with marker D11S4158. It is
probable that the hydrolethalus locus lies in the vicinity
of marker D11S1896 and that the ancient recombina-
tions of marker D11S4158 limit the locus on the cen-
tromeric side, but since allele 4 with marker D11S1896
was very common in the control chromosomes, the cen-
tromeric border of the hydrolethalus locus cannot be
confirmed with complete certainty as lying at marker
D11S4158. Markers D11S933 on the centromeric and
D11S934 on the telomeric side limit the possible gene
locus, there being several ancient recombinations.
Construction of the haplotype by use of markers
D11S4158, D11S1896, and D11S934 was possible in
22 disease chromosomes (families 1 and 3–12, for which
DNA samples from both parents were available). With
these three markers, two ancient core haplotypes were
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Table 2
Pairwise LOD Scores between Hydrolethalus
Syndrome and 13 Marker Loci on Chromosome
11q23-25 in Eight Families
LOCUS
LOD SCORE AT v =
0 .01 .05 .10 .20
D11S1353  2.44 2.60 2.26 1.40
D11S4144  2.45 2.68 2.40 1.58
D11S4094 3.25 3.15 2.75 2.26 1.36
D11S4464 3.77 3.67 3.26 2.75 1.76
D11S1328 4.66 4.53 4.00 3.34 2.10
D11S1752 2.71 2.64 2.33 1.95 1.23
D11S933 3.08 2.99 2.61 2.16 1.32
D11S4158 3.70 3.60 3.17 2.63 1.64
D11S1896 3.91 3.80 3.37 2.83 1.80
D11S934 4.57 4.45 3.94 3.31 2.10
D11S4110 4.03 3.91 3.45 2.89 1.81
D11S1351  0.66 1.10 1.07 0.75
D11S912  1.15 2.04 2.01 1.40
Bold type indicates the maximum LOD score for
each marker.
observed: 8 of the 22 disease chromosomes carried hap-
lotype 1–4–5, and seven chromosomes carried haplotype
1–4–11. The distribution of ancestors’ birthplaces for
these haplotypes was monitored, but neither group of
great-grandparents revealed any obvious regional clus-
tering. Since allele 1 with marker D11S4158 was equally
present in chromosomes carrying allele 5 or 11 with
marker D11S934, we consider it improbable that these
two ancestral haplotypes represent two different found-
ing mutations. It is more likely that ancient recombi-
nation events have taken place between markers
D11S1896 and D11S934.
Discussion
When attempting to identify the locus for amonogenic
disease with no known biochemical abnormalities, it is
essential to have sufficient family material with reliable
diagnoses. Differential diagnosis between hydrolethalus
syndrome and other malformation syndromes has
proven to be difficult—hydrolethalus syndrome as a dis-
ease entity was actually discovered in the course of a
study of another lethal malformation syndrome, Meckel
syndrome, in Finland (Salonen et al. 1981). The diffi-
culties of differential diagnostics in multiplemidlinemal-
formation syndromes have been discussed in several
publications. In 1991, Hennekam et al. described a sib-
pair with multiple symptoms characteristic of hydrole-
thalus syndrome but concluded that they represented a
separate entity, pseudotrisomy 13 syndrome. In 1993,
Pryde et al. discussed the problems of prenatal differ-
ential diagnosis between hydrolethalus, severe Smith-
Lemli-Opitz, orofaciodigital type IV and VI, pseudotri-
somy 13, and Pallister-Hall syndromes and concluded
that it was unclear whether similar or related pathoge-
netic defects lie behind these syndromes or whether they
represent similar phenotypic expressions of several
unique molecular defects. In 1995, Verloes compared
these syndromes, using numerical syndromology, and
concluded that the five syndromes are clearly indepen-
dent phenotypic entities. Later, mutations in the D7-
sterol reductase gene (DHCR7, chr 11q13) have been
proven to cause Smith-Lemli-Opitz syndrome (Cormier-
Daire et al. 1996; Fitzky et al. 1998; Wassif et al. 1998;
Waterham et al. 1998) and mutations in the GLI3 gene
(chr 7p13) to cause Pallister-Hall syndrome (Kang et al.
1997a, 1997b). Meckel syndrome has proven to be a
heterogeneous disease and has been mapped to chro-
mosome 17q22 in the Finnish population and to 11q13
in Middle Eastern and North African families (Paavola
et al. 1995; Roume et al. 1998; Salonen and Paavola
1998). So far, the molecular defects behind orofaciodi-
gital syndrome types IV and VI and pseudotrisomy 13
syndrome are not known.
Although the diagnosis of hydrolethalus syndrome is
problematic, we are convinced that the family material
used in our linkage and linkage-disequilibrium studies
consists of true hydrolethalus cases. The syndrome is
common enough in Finland to be recognized by spe-
cialists, and we included only highly typical cases in this
study. The genealogical studies also suggested that, as
in several other Finnish diseases (Peltonen et al. 1995),
one major founding mutation could be predicted. Thus,
we considered the family material sufficient for a link-
age-based genomewide scan. The results of the linkage
and linkage-disequilibrium analyses revealed that all our
study families were linked to the same locus and that
every disease chromosome carried the same allele 4 with
marker D11S1896, demonstrating locus and allelic ho-
mogeneity in hydrolethalus syndrome in Finland. How-
ever, since 33% of the control chromosomes carried the
same allele 4 with marker D11S1896, we cannot be to-
tally convinced that there is only one ancestral mutation
before we have a yet denser marker map and can find
a haplotype specific to hydrolethalus-carrying chromo-
somes with several markers.
This mapping project is—like many other mapping
projects of the Finnish disease heritage—a good example
of the power of linkage disequilibrium in disease-gene
mapping in genetic isolates. Using linkage-disequilib-
rium analyses, it is possible to limit the critical chro-
mosomal region after conventional linkage analysis be-
fore starting the construction of a physical map or
candidate-gene analyses; in this study, the critical genetic
interval decreased from an initial 8.5 cM to 0.5–1 cM.
When the family material available for linkage studies
is limited, linkage disequilibrium also confirms the re-
sults of linkage analysis. In this study, the two-point
LOD scores of 2.7–4.7, obtained with nine markers,
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Figure 5 Multipoint linkage-disequilibrium analysis of nine
markers in the linkage region with 30 hydrolethalus chromosomes and
105 control chromosomes
Table 3
Allele Frequencies in Hydrolethalus and Control Chromosomes and Two-Point Linkage-Disequilibrium Analyses of Nine Marker Loci on
11q23-25
LOCUS
PERCENTAGE OF HYDROLETHALUS CHROMOSOMES ( ) /n = 30
PERCENTAGE OF CONTROL CHROMOSOMES ( ) FOR ALLELEn = 105
x2
LRTa P lb1 2 3 4 5 6 7 8 9 10 11 12 13
D11S4094 7/17 7/13 7/12 3/10 73/35 0/6 0/7 3/0 ) ) ) ) ) 10.9 .0005 .56
D11S4464 3/6 53/35 23/30 13/18 7/7 0/5 ) ) ) ) ) ) ) 1.0 .2 .26
D11S1328 40/7 30/29 13/31 3/8 3/1 10/20 0/4 0/1 ) ) ) ) ) 12.0 .0003 .35
D11S1752 10/31 7/13 83/57 ) ) ) ) ) ) ) ) ) ) 6.6 .005 .61
D11S933 0/3 17/9 0/1 63/53 7/21 3/2 0/1 10/9 0/1 0/1 ) ) ) .0 .4 .06
D11S4158 77/16 0/3 3/7 7/45 13/24 0/2 0/1 0/1 0/1 0/1 ) ) ) 35.2 !.0001 .72
D11S1896 0/14 0/10 0/43 100/33 ) ) ) ) ) ) ) ) ) 51.2 !.0001 1.00
D11S934 0/1 13/22 0/3 0/11 40/41 0/4 0/4 3/1 0/2 3/4 33/2 3/6 3/0 13.6 .0001 .31
D11S4110 10/10 0/1 20/32 0/3 20/21 33/20 17/12 0/1 ) ) ) ) ) .0 .5 .00
Bold type indicates alleles showing strong association with hydrolethalus syndrome.
a x2 statistic of the likelihood-ratio test (Terwilliger 1995).
b Proportion of excess of a certain allele in the hydrolethalus chromosomes.
were satisfactory, but the result of multipoint linkage-
disequilibrium analysis, providing a LOD score of 21.1,
left no room for doubt about the locus assignment.
The regional distribution of the ancestors of families
affected by hydrolethalus in the late-settlement region
of Finland resembles those of infantile-onset spinocer-
ebellar ataxia (IOSCA) (Varilo et al. 1996) and the new
Finnish metabolic syndrome with iron accumulation (Vi-
sapa¨a¨ et al. 1998). These disease mutations were most
probably introduced into the Finnish population around
the same time, some 30–40 generations ago. No obvious
clustering of ancestors was observed, nor does the dis-
tribution of the ancestors’ birthplaces reflect the distri-
bution of the current Finnish population. As in IOSCA
and the new metabolic syndrome, the distribution re-
sembles the routes of the internal migration in the 1500s,
from the southeastern county of Savo, and suggests that
the disease alleles were introduced into subpopulations
during this inland inhabitation process (Norio 1981).
Compared to IOSCA and the new metabolic syndrome,
the distribution of ancestors stretches somewhat further
into the area of early settlement, suggesting that this
mutation was introduced somewhat earlier. That there
are fewer identified consanguineous families than in the
case of IOSCA lends further support to this theory. The
size of the common core haplotype and the interval re-
vealing very significant linkage disequilibrium in two-
point analysis ( ) spans 2 cM in IOSCA (NikaliP ! .0001
et al. 1995; Varilo et al. 1996), 1 cM in the new met-
abolic syndrome (Visapa¨a¨ et al. 1998), and 0.5 cM in
hydrolethalus syndrome, further supporting the hypoth-
esis that the hydrolethalus mutation is the oldest of the
three. In fact, considering the similarity of the distri-
bution of the ancestors in these three diseases, this chro-
mosomal interval is surprisingly small in hydrolethalus
syndrome, but this could also be due to inaccuracies in
the genetic and RH maps.
There are 10 cloned genes and 80 expressed sequence
tags in the 9-cM interval between D11S1353 and
D11S1351 in the NewGeneMap of theHumanGenome
of the National Center for Biotechnology Information.
Some of the genes can be excluded as candidate genes
for hydrolethalus syndrome on the basis of their known
specific function or expression in only a few tissues—for
example, two testis-specific genes, ZNF202 and ACRV1
(Golden et al. 1993; Monaco et al. 1998). However,
many of the genes encode proteins involved in very basic
cell functions—for example, potassium channel KCNJ1,
sialyltransferase SIAT4C, and signal-recognition particle
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Table 4
Haplotypes of the Hydrolethalus-Carrying Chromosomes with Nine Marker Loci
Familya D11S4094 D11S4464 D11S1328 D11S1752 D11S933 D11S4158 D11S1896 D11S934 D11S4110
1P 5 2 3 3 8 5 4 12 3
1M 2 3 2 3 4 1 4 5 6
2P 5 3 2 2/3b 2 1/4b 4 11* 5*
2M 5 5 2 2/3b 4 1/4b 4 5 5
3P 5 4 6 3 8 5 4 11* 7
3M 5 3 5 3 4 3 4 5 3
4P 5 2 1 3 4 1 4 2 6
4M 5 2 1 3 4 1 4 11* 1
5P 5 2 1 3 4/5b 1 4 5 1
5M 5 2 1 3 4/5b 1 4 11* 5*
6P 5 2 1 3 4 1 4 11* 5*
6M 5 2 1 3 4 1 4 10 6
7P 5 2 1 3 5 1 4 5 1
7M 5 5 2 2 4 1 4 5 6
8P 5 4 2 3 2 1 4 5 7
8M 5 4 2 3 2 1 4 5 7
9P 2 3 1 1 6 4 4 5 3
9M 5 4 2 3 2 1 4 5 6
10P 8 1 2 3 4 1 4 5 6
10M 1 3 6 3 2 1 4 11* 5*
11P 5 2 1 3 4 1 4 11* 6
11M 3 2 3 1 4 1 4 11* 3
12P 5 2 3 1 4 5 4 2 7
12M 5 2 1 3 4 1 4 11* 7
NOTE.—Underlining indicates alleles which are part of the most common haplotype, and asterisks indicate an alternative telomeric
end of that haplotype.
a aternal disease chromosome; aternal disease chromosome.P = p M = m
b Not possible to determine which of the alleles originates from the paternal and which from the maternal disease chromosome.
receptor SRPR. Although these genes are not directly
known to be involved in embryogenesis, they cannot be
excluded as candidate genes for hydrolethalus syndrome
in view of their important role in cell functions. Which
of the regional genes are located in the restricted critical
chromosomal region and, thus, deserve closer consid-
eration and analysis as candidate genes, remains to be
analyzed when a complete physical map of the region
has been constructed.
Linkage analysis can now be provided to families with
a previous child with hydrolethalus syndrome to confirm
the prenatal diagnosis as early as possible. At present
prenatal diagnosis of hydrolethalus syndrome is done
ultrasonographically (Hartikainen-Sorri et al. 1983;
A¨mma¨la¨ and Salonen 1995). For pregnancies with a
known risk for hydrolethalus syndrome, a vaginal ul-
trasound examination can be performed at 11–12 wk
of pregnancy, when the earliest signs of the syndrome
can be detected. The diagnosis can be confirmed at
13–15 wk by an experienced clinician who knows the
typical ultrasonographic features of the syndrome. Be-
sides the diagnostics of Finnish cases, from now on, the
segregation-based haplotype analysis can be used to ad-
dress the issue of locus heterogeneity in non-Finnish
cases. Most importantly, the precise positioning of the
hydrolethalus-syndrome locus in the genome will now
allow the disease-causing gene to be cloned and the mo-
lecular mechanisms behind this severe developmental
disturbance to be revealed.
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